
Hatim Husain
@hatimhusainmd
Medical oncologist. Interested in translational studies and new drug development.
ID: 906536754890641409
09-09-2017 15:16:19
138 Tweet
477 Followers
170 Following

Day 2 of #LATAMoncoSummit dedicated to the care of patients with EGFR exon 20 insertion mutations focusing on current strategies to detect these alterations when NGS is not available w W. William Vladmir C. Cordeiro de Lima, MD, PhD Jorge Alatorre Alexander Hatim Husain #LOS2023


Don't forget to join us for our monthly Lung Cancer Series Webinar on Sept 27th at 6pm! Register here: bit.ly/3ZAswM3. Come learn about neoadjuvant and adjuvant therapy with our experts Hatim Husain Patrick Forde and Dr. Joshua Boys. UC San Diego Health Moores Cancer Center Johns Hopkins Kimmel Cancer Center


#ScienceLink #OncoCast Dra. Maritza Ramos (Maritza Ramos MD) y Dr. Hatim Husain (Hatim Husain) Osimertinib redujo el riesgo de muerte en un 51% en comparación con placebo en la población del análisis primario


Our #LungCancer Webinar Series continues this month with our #radonc colleagues Chien Pong (Peter) Chen, MD, @scrippshealth, Ajay Sandhu, MD, @ucsdhealth and moderator Hatim Husain. Listen in as they discuss their preferred treatment for stage 3 disease youtu.be/MI7wKWvLh34


Join is THIS Wed, Nov 29th at 6pm for another episode of our #LungCancer Webinar Series! Learn more about antibody drug conjugates from Dr. Aaron Lisberg . and Aaron Mansfield Mayo Clinic, moderated by Hatim Husain UC San Diego Health Moores Cancer Center. Register: bit.ly/3sRRkmU




Hatim Husain explained the significance of the PACIFIC trial and PACIFIC-R looking at the use of durvalumab after chemotherapy and radiation in patients with unresectable stage III #NSCLC. #lcsm targetedonc.com/view/husain-ev…

So excited to meet and share insights on precision oncology and liquid biopsy strategies at the WIN Symposium 2024 in Abu Dhabi! #WINSYMPO2024 @winconsortium Burjeel Holdings


Global Oncology Leaders Converge as Abu Dhabi Hosts its First WIN Symposium uaenews4u.com/2024/03/01/glo… WIN Consortium Burjeel Holdings Razelle Kurzrock, MD @JimAllisonPhD @PamSharmaMDPhD Khaled Musallam MD PhD Prof.Dr.Humaid Al-Shamsi 🇦🇪 Dr. Shamsheer Vayalil Jake Scott Hatim Husain Sendurai Mani

WATCH: Hatim Husain provides an overview of adverse effects and management with KRAS targeted and immunotherapy combinations. #lcsm targetedonc.com/view/toxicity-…

Lung cancer in individuals who have never smoked (LCINS) is estimated to be the fifth most common cause of cancer-related deaths globally. A Review in NatureRevClinOncol reviews the emerging data regarding the causes and features of LCINS. 🔒 go.nature.com/3TcfOQO


Thanks to ESMO - Eur. Oncology ESMO Daily for highlighting our paper in Clinical Cancer Research Tumor Fraction #liquidbiopsy. This is an important concept to distinguish non shedders to non informative LB. Lincoln Pasquina Hatim Husain The Tisch Cancer Institute Great comment by Umberto Malapelle dailyreporter.esmo.org/news/liquid-bi…



Join us TONIGHT @ 6pm for our Lung Cancer Webinar Series! We’ll be discussing early stage #NSCLC with Hatim Husain and Dr. Joshua Boys UC San Diego Health Moores Cancer Center and Joel W. Neal, MD, PhD Stanford Cancer Institute. Register here: moasc.org/meetinginfo.ph…


Symposium for Evolving Therapies and Drug Development in Oncology #ET24 Raymond Wadlow MD Jafar Al-Mondhiry, MD, MA Elad Sharon Triparna Sen (Sen-Lab) Hatim Husain Rafeh Naqash, MD Asrar AlAhmadi, MD, MAS-CR - أسرار الأحمدي Inova Schar Cancer Institute search.app/wfhMyVbjJZ8iyq…

Join us September 7-9 in San Diego for sessions on SCLC, ADCs, and NSCLC at our San Diego Lung Symposia! Register now: bit.ly/3WCKcWi #gotoPER #WCLC24 Misty Dawn Shields Jacob sands Charu Aggarwal, MD, MPH, FASCO Hatim Husain

Wanted to express gratitude towards Hatim Husain for his sponsorship allowing me to share our work at #WCLC24 Little did I know I’d be presenting next to THE Heather Wakelee #lcsm #medtwitter


Today! We welcomed Hatim Husain, M.D. to Grand Rounds! #MedTwitter #lungcancer UC San Diego School of Medicine Hatim Husain UC San Diego Health Moores Cancer Center UC San Diego Health


Great talks last week at OncLive State of the Science Summit: Lung Cancer hosted by Jyoti Malhotra in ☀️Pasadena with talks by Hatim Husain on BRAF/KRAS and Jorge Nieva on ADCs snd Dr Antrim on EGFR and my presentation on updates on ALK+ field
